fig1
From: Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
Figure 1. Different mechanisms of cancer drug resistance. A: elevated drug efflux, B: change in the cell metabolism, C: genetic modifications of the drug target, D: enhanced DNA damage response, E: inhibition of apoptosis
